The Coagulation Cascade in Cirrhosis

Clinics in Liver Disease

Volumn 13, Issue 1, 2009, Pages 1-9

  Monroe, Dougald M ^a   Hoffman, Maureane ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coagulation factors; Hemorrhage; Hemostasis; Platelets; Thrombin

Indexed keywords

ANTICOAGULANT PROTEIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A; PROTEIN C; PROTEIN S; PROTEINASE INHIBITOR; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; HEMOSTASIS; HUMAN; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REVIEW; RISK FACTOR; THROMBIN TIME; THROMBOCYTE MEMBRANE; THROMBOSIS;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; HEMORRHAGE; HEMOSTASIS; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; MODELS, BIOLOGICAL; PROTHROMBIN TIME; THROMBIN; THROMBOPLASTIN; THROMBOSIS;

EID: 58149339649     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.09.014     Document Type: Review

References (36)

1. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 202 (1964) 498-499
2. Davie E.W., and Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 145 (1964) 1310-1312
3. Eagle H., and Harris T.N. Studies in blood coagulation: V. The coagulation of blood by proteolytic enzymes (trypsin, papain). J Gen Physiol 20 (1937) 543-560
4. Bizzozero J. Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der butgerinnung. Virchows Arch Pathol Anat Physiol Klin Med 90 (1882) 261-332
5. Hayem G. Recherches sur l'évolution des hématies dans le sang de l'homme et des vertébrés. Arch Physiol 2 (1879) 201-261
6. Chargaff E., Bancroft F.W., and Stanley-Brown M. Studies on the chemistry of blood coagulation III. The chemical consitituents of blood platelets and their role in blood clotting, with remarks on the activation of clotting by lipids. J Biol Chem 116 (1936) 237-251
7. Hoffman M., and Monroe III D.M. A cell-based model of hemostasis. Thromb Haemost 85 (2001) 958-965
8. Drake T.A., Morrissey J.H., and Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134 (1989) 1087-1097
9. Rao L., and Rapaport S.I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A 85 (1988) 6687-6691
10. Østerud B., and Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 74 (1977) 5260-5264
11. Tracy P.B., Rohrbach M.S., and Mann K.G. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem 258 (1983) 7264-7267
12. Le D., Borgs P., Toneff T., et al. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol 274 (1998) H769-H776
13. Hoffman M., Colina C.M., McDonald A.G., et al. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost 5 (2007) 1403-1408
14. Bauer K.A., Mannucci P.M., Gringeri A., et al. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood 79 (1992) 2039-2047
15. Hung D.T., Vu T.K., Wheaton V.I., et al. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 89 (1992) 1350-1353
16. Hoffman M., Monroe D.M., and Roberts H.R. Cellular interactions in hemostasis. Haemostasis 26 Suppl 1 (1996) 12-16
17. Oliver J., Monroe D., Roberts H., et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 19 (1999) 170-177
18. Baglia F.A., and Walsh P.N. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Biochemistry 37 (1998) 2271-2281
19. Franssen J., Salemink I., Willems G.M., et al. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor. Biochem J 323 Pt 1 (1997) 33-37
20. Lu G., Broze G.J.J., and Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 279 (2004) 17241-17249
21. Fair D.S., and Marlar R.A. Biosynthesis and secretion of factor VII, protein C, protein S, and the protein C inhibitor from a human hepatoma cell line. Blood 67 (1986) 64-70
22. Esmon C.T., Stenflo J., and Suttie J.W. A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase. J Biol Chem 251 (1976) 3052-3056
23. Oliver J.A., Monroe D.M., Church F.C., et al. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood 100 (2002) 539-546
24. Esmon C.T. The endothelial protein C receptor. Curr Opin Hematol 13 (2006) 382-385
25. Cadroy Y., Diquelou A., Dupouy D., et al. The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium. Arterioscler Thromb Vasc Biol 17 (1997) 520-527
26. Esmon C., Esmon N., and Hams K. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 257 (1982) 7944-7947
27. Dahlback B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 79 (2004) 109-116
28. Fay P.J., Smudzin T.M., and Walker F.J. Activated protein C-catalyzed inactivation of human factor VIII and VIIIa. J Biol Chem 266 (1991) 20139-20145
29. Jennings I., Calne R.Y., and Baglin T.P. Predictive value of von Willebrand factor to ristocetin cofactor ratio and thrombin-antithrombin complex levels for hepatic vessel thrombosis and graft rejection after liver transplantation. Transplantation 57 (1994) 1046-1051
30. De Caterina M., Tarantino G., Farina C., et al. Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S. Haemostasis 23 (1993) 229-235
31. Raya-Sanchez J.M., Gonzalez-Reimers E., Rodriguez-Martin J.M., et al. Coagulation inhibitors in alcoholic liver cirrhosis. Alcohol 15 (1998) 19-23
32. Tripodi A., Salerno F., Chantarangkul V., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
33. Ben-Ari Z., Osman E., Hutton R.A., et al. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?. Am J Gastroenterol 94 (1999) 2977-2982
34. Violi F., Ferro D., Basili S., et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 109 (1995) 531-539
35. Tripodi A., Primignani M., Chantarangkul V., et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 44 (2006) 440-445
36. Lisman T., Bongers T.N., Adelmeijer J., et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 44 (2006) 53-61